Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy

被引：7

作者：

Saliba, Antoine N. ^{[1
,2
]}

Xie, Zhuoer ^{[1
,2
]}

Higgins, Alexandra S. ^{[1
,2
]}

Andrade-Gonzalez, Xavier A. ^{[1
,2
]}

Fuentes-Bayne, Harry E. ^{[1
,2
]}

Hampel, Paul J. ^{[1
,2
]}

Kankeu Fonkoua, Lionel A. ^{[1
,2
]}

Childs, Daniel S. ^{[1
,2
]}

Rakshit, Sagar ^{[1
,2
]}

Bezerra, Evandro D. ^{[1
,2
]}

Kommalapati, Anuhya ^{[1
,2
]}

Lou, Yanyan ^{[3
]}

Rivera, Candido E. ^{[3
]}

Price, Katharine A. ^{[2
]}

Chintakuntlawar, Ashish ^{[2
]}

Yan, Yiyi ^{[2
]}

Schwecke, Anna J. ^{[2
]}

Block, Matthew S. ^{[2
]}

Thanarajasingam, Uma ^{[4
]}

Thanarajasingam, Gita ^{[1
]}

Wolanskyj-Spinner, Alexandra P. ^{[1
]}

Marshall, Ariela L. ^{[1
,5
]}

Kottschade, Lisa A. ^{[2
]}

Go, Ronald S. ^{[1
]}

Al-Kali, Aref ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, 200 1 St SW, Rochester, MN USA

[2] Mayo Clin, Dept Oncol, Div Med Oncol, Rochester, MN USA

[3] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL USA

[4] Mayo Clin, Div Rheumatol, Rochester, MN USA

[5] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 10期

关键词：

RITUXIMAB;

D O I：

10.1002/ajh.26273

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E362 / E367

页数：6

共 50 条

[31] Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Koji Haratani
Hidetoshi Hayashi
Kazuhiko Nakagawa
BMC Medicine, 18
[32] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge Reply
Dolladille, Charles
Da-Silva, Angelique
Alexandre, Joachim
JAMA ONCOLOGY, 2020, 6 (11) : 1814 - 1815
[33] Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy
Kersh, Anna E.
Schuchter, Lynn M.
Elenitsas, Rosalie
Chu, Emily Y.
IMMUNOTHERAPY, 2020, 12 (13) : 951 - 956
[34] Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer.
Ou, Qiyun
Yu, Yunfang
Zhong, Haitao
Li, Anlin
Chen, Yongjian
Zhou, Haiyu
Zheng, Shaopeng
Huang, Luyu
Yao, Herui
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[35] Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Haratani, Koji
Hayashi, Hidetoshi
Nakagawa, Kazuhiko
BMC MEDICINE, 2020, 18 (01)
[36] Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Dolladille, Charles
Ederhy, Stephane
Sassier, Marion
Cautela, Jennifer
Thuny, Franck
Cohen, Ariel A.
Fedrizzi, Sophie
Chretien, Basile
Da-Silva, Angelique
Plane, Anne-Flore
Legallois, Damien
Milliez, Paul U.
Lelong-Boulouard, Veronique
Alexandre, Joachim
JAMA ONCOLOGY, 2020, 6 (06) : 865 - 871
[37] Immune-related adverse events of checkpoint inhibitors
Ramos-Casals, Manuel
Brahmer, Julie R.
Callahan, Margaret K.
Flores-Chavez, Alejandro
Keegan, Niamh
Khamashta, Munther A.
Lambotte, Olivier
Marlette, Xavier
Prat, Aleix
Suarez-Almazor, Maria E.
NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
[38] Immune-related adverse events of checkpoint inhibitors
Manuel Ramos-Casals
Julie R. Brahmer
Margaret K. Callahan
Alejandra Flores-Chávez
Niamh Keegan
Munther A. Khamashta
Olivier Lambotte
Xavier Mariette
Aleix Prat
Maria E. Suárez-Almazor
Nature Reviews Disease Primers, 6
[39] Immune-related adverse events of checkpoint inhibitors
不详
Nature Reviews Disease Primers, 6 (1) : 39
[40] Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review
Capaccione, Kathleen M.
Valiplackal, Jacienta P.
Huang, Alice
Roa, Tina
Fruauff, Alana
Liou, Connie
Kim, Eleanor
Khurana, Sakshi
Maher, Mary
Ma, Hong
Ngyuen, Pamela
Mak, Serena
Dumeer, Shifali
Lala, Sonali
D'souza, Belinda
Laifer-Narin, Sherelle
Desperito, Elise
Ruzal-Shapiro, Carrie
Salvatore, Mary M.
ACADEMIC RADIOLOGY, 2022, 29 (12) : 1869 - 1884

← 1 2 3 4 5 →